Jennifer Grandis | |
---|---|
Born | 1960 (age 60–61) |
Academic background | |
Education | BA, Biology, 1982, Swarthmore College MD, 1987, University of Pittsburgh |
Academic work | |
Institutions | University of California, San Francisco University of Pittsburgh |
Jennifer Rubin Grandis (born 1960) is an American otolaryngologist, focusing in general otolaryngology and clinical and translational research. Her research interests include diagnosis and treatment of head and neck cancer. She is a Full professor at the University of California, San Francisco having previously worked as the UPMC Endowed Chair at University of Pittsburgh.
Grandis was born in 1960. [1] She earned her Bachelor of Arts degree from Swarthmore College in 1982 before enrolling at the University of Pittsburgh (UPitt) for her medical degree. [2] She completed her residency at the UPMC Department of Otolaryngology in 1993 and became a research fellow for the School of Medicine’s Division of Infectious Diseases in 1991. [3]
Following her residency and fellowship, Grandis accepted a faculty position at the University of Pittsburgh and was elected a member of the American Society for Clinical Investigation. [4] During her tenure at Pitt, Grandis developed a personalized medicine approach to studying head and neck squamous cell carcinoma by looking at underlying genetic abnormalities in an individual’s cancer. In recognition of her efforts, she became the first American Cancer Society - Genentech BioOncology Clinical Research Professor for Translational Research. [5] The following year, while serving as the UPMC Endowed Chair in Head and Neck Cancer Surgical Research, Grandis was the recipient of a Chancellor’s Distinguished Research Award. [6]
By 2010, Grandis' alternate approach to develop a new DNA therapy for head and neck cancers was approved by the U.S. Patent and Trademark Office. The therapy targets the epidermal growth factor receptor (EGFR), a protein found on the surface of many types of cancer cells that causes them to multiply. [7] Grandis was eventually appointed Distinguished Professor and Vice Chair for Research in the Department of Otolaryngology, [3] where she was elected a Member of the Institute of Medicine. [8] In 2014, Grandis and her husband accepted faculty positions at the University of California, San Francisco. She became the Associate Vice Chancellor of Clinical and Translational Research and her husband joined the faculty in the Division of Cardiology. [9]
In 2019, Grandis continued to study diagnosis and treatment of head and neck cancer and published the first study to show a strong clinical advantage of regular NSAID use for head and neck cancer patients with mutations in the PIK3CA gene. [10] In recognition of her efforts, she was the recipient of the 2019 AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship. [11] The following year, Grandis accepted an appointment as a Special Consultant to National Institute on Deafness and Other Communication Disorders Director Debara L. Tucci. The aim of her appointment was to "collaborate to determine future directions of the clinical program, advise on clinical trials, and add value with regard to data management." [12]
Grandis and her husband Don have two children together; a son and daughter. [13]
The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and it is dedicated entirely to health science. It is a major center of medical and biological research and teaching.
The University of Pittsburgh Medical Center (UPMC) is a $21 billion integrated global nonprofit health enterprise that has 90,000 employees, 40 hospitals with more than 8,000 licensed beds, 700 clinical locations including outpatient sites and doctors' offices, a 3.8 million-member health insurance division, as well as commercial and international ventures. It is closely affiliated with its academic partner, the University of Pittsburgh. It is considered a leading American health care provider, as its flagship facilities have ranked in U.S. News & World Report "Honor Roll" of the approximately 15 to 20 best hospitals in America for over 15 years. As of 2016, flagship hospital, UPMC Presbyterian is ranked 12th nationally among the best hospitals by U.S. News & World Report and ranked in 15 of 16 specialty areas when including UPMC Magee-Womens Hospital. This does not include UPMC Children's Hospital of Pittsburgh which ranked in the top 10 of pediatric centers in a separate US News ranking.
The University of Pittsburgh School of Medicine is the medical school of the University of Pittsburgh, located in Pittsburgh, Pennsylvania. The School of Medicine, also known as Pitt Med, is consistently ranked as a "Top Medical School" by U.S. News & World Report in both research and primary care. It is ranked 13th in the category of research and 14th in primary care by U.S. News for 2020, and is separately ranked 17th in the Academic Ranking of World Universities list of best medical schools in the world. The school encompasses both a medical program, offering the doctor of medicine, and graduate programs, offering doctor of philosophy and master's degrees in several areas of biomedical science, clinical research, medical education, and medical informatics.
Mark A. Nordenberg is the chancellor emeritus of the University of Pittsburgh and chair of the university's Institute of Politics. A professor of law and university administrator, Nordenberg served as the seventeenth Chancellor of the University of Pittsburgh from 1996 to 2014. Nordenberg served as the Dean of the University of Pittsburgh School of Law between 1985 and 1993 and other various administrative positions before becoming interim Chancellor of the University of Pittsburgh in 1995, a position which became permanent the following year. He became known as Nordy to many Pitt students, who voted to name a recreation center and arcade in the William Pitt Union as Nordy's Place, and is also the namesake of the university's endowed Nordenberg Scholarships and the Nordenberg Hall dormitory on the university's campus.
Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014–2020. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.
The UPMC Hillman Cancer Center (Hillman), previously titled the University of Pittsburgh Cancer Institute (UPCI), is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center located in the Hillman Cancer Center in the Shadyside neighborhood of Pittsburgh, Pennsylvania, United States, adjacent to UPMC Shadyside. The only NCI-designated cancer center in Western Pennsylvania, Hillman is composed of collaborative academic and research efforts between the University of Pittsburgh, the University of Pittsburgh Medical Center (UPMC), and Carnegie Mellon University. Hillman provides clinical cancer care to some 74,000 patients treated at its facilities at both the flagship Hillman Cancer Center location in the Shadyside neighborhood of Pittsburgh and at dozens of UPMC-affiliated sites throughout Pennsylvania, New York, Ohio, and a growing list of overseas locations. Founded in 1984, Hillman became the youngest cancer center in history to achieve NCI-designation, and as of 2007 received nearly $200 million in funding from the National Cancer Institute ranking it in the top ten of all cancer research institutes.
Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.
Joel S. Schuman is an American ophthalmologist, specializing in glaucoma. In 2020 he was named Elaine Langone Professor and Vice Chair for Research in the Department of Ophthalmology at NYU Langone Medical Center, NYU Grossman School of Medicine, having served as Chairman of that Department and Director of the NYU Langone Eye Center 2016-2020. In 2016 he was also appointed Professor of Electrical and Computer Engineering at NYU Tandon School of Engineering, and Professor of Neuroscience and Physiology and a member of the Neuroscience Institute, at NYU Langone Health, NYU Grossman School of Medicine. In 2017 he became Professor of Neural Science in the Center for Neural Science at NYU. In 2018 he was named Professor and core faculty in the newly formed Department of Biomedical Engineering at NYU Tandon School of Engineering. From 2003 - 2016 he was the Professor and Chairman of Ophthalmology at the Eye and Ear Institute, University of Pittsburgh School of Medicine, the Eye and Ear Foundation Endowed Chair and Director of the University of Pittsburgh Medical Center (UPMC) Eye Center. He was also Professor of Bioengineering at the Swanson School of Engineering, University of Pittsburgh and Director of the Louis J. Fox Center for Vision Restoration of UPMC and the University of Pittsburgh. He was a member of the McGowan Institute for Regenerative Medicine and the Center for the Neural Basis of Cognition, Carnegie Mellon University and University of Pittsburgh. He became a Distinguished Professor of Ophthalmology at the University of Pittsburgh in September 2014.
Eugene Nicholas Myers is an oncologist and otolaryngologist and a leader in the treatment of head and neck cancer. He has served on the faculty of the University of Pittsburgh School of Medicine since 1972, when he became chairman of the Department of Otolaryngology. He is the author or co-author of leading texts in the field of head and neck cancer, and has chaired and served on the boards of the preeminent societies and associations in the field.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research into T cell therapies for the treatment of cancer. In 2020 he was elected to the American Philosophical Society.
Nancy E. Davidson is the executive director and president of Seattle Cancer Care Alliance, senior vice president, director of clinical oncology at Fred Hutchinson Cancer Research Center and head of the Division of Medical Oncology at the University of Washington School of Medicine. She focuses her research on breast cancer treatments and the genes that are mutated in various forms of breast cancer. She was president of American Association for Cancer Research from 2015 to 2016 and president of American Society of Clinical Oncology from 2007 to 2008.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Cecilia Wen-ya Lo is a professor and the F. Sargent Cheever Chair of Developmental Biology at the University of Pittsburgh. Her research focuses on the study of congenital heart defects.
UPMC Presbyterian is a 900-bed non-profit, research and academic hospital located in the Oakland neighborhood of Pittsburgh, Pennsylvania, providing tertiary care for the Western Pennsylvania region and beyond. It comprises the Presbyterian campus of the combined UPMC Presbyterian Shadyside hospital entity. The medical center is a part of the University of Pittsburgh Medical Center health system and is the flagship hospital of the system. UPMC Presbyterian also features a state verified Level 1 Trauma Center, 1 of 3 in Pittsburgh. Although UPMC Presbyterian has no pediatric services, Presby has the equipment to stabilize and transfer pediatric emergency cases to the nearby UPMC Children's Hospital of Pittsburgh.
Sharon Louise Hillier is an American microbiologist. She is the Richard Sweet Endowed Chair in Reproductive Infectious Disease and vice chair of the department of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh Medical Center (UPMC) and Magee-Women's Research Institute.
Lucile L. Adams-Campbell is the first African-American woman to receive a PhD in epidemiology in the United States. She serves as the Professor of Oncology at Lombardi Comprehensive Cancer Center and Associate Director for Minority Health at the Georgetown University Medical Center. She is a Fellow of the National Academy of Medicine and the Washington DC Hall of Fame.
Roy S. Herbst MD, PhD is the Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center and Yale School of Medicine in New Haven, Connecticut.
Karen E. Knudsen is the Hilary Koprowski Endowed Professor of Oncology at Thomas Jefferson University in Philadelphia, Pennsylvania. She also holds secondary appointments in the Departments of Urology, Medical Oncology, and Radiation Oncology. She is Executive Vice President of Oncology Services, Jefferson Health and Enterprise Director of its Sidney Kimmel Comprehensive Cancer Center, one of 71 NCI-designated cancer centers in the United States.
UPMC Shadyside, is a nationally ranked, 520-bed non-profit, tertiary, teaching hospital located in the Shadyside neighborhood of Pittsburgh, Pennsylvania. UPMC Shadyside is a part of the University of Pittsburgh Medical Center (UPMC), and grouped in with the flagship UPMC Presbyterian. The hospital is near UPMC's flagship campus which houses Presbyterian and Montefiore. As the hospital is a teaching hospital, it is affiliated with University of Pittsburgh School of Medicine. The hospital has an emergency room to handle emergencies, with a rooftop helipad to transport critical patients to and from the hospital. UPMC Shadyside houses the flagship campus of the UPMC Hillman Cancer Center, a nationally ranked cancer hospital.